Pricing Supplement |
Filed Pursuant to Rule 424(b)(2) |
(To Prospectus dated December 30, 2022 |
Registration
No. 333-268718 |
and Series P MTN Prospectus Supplement dated December 30, 2022)
November 26, 2024 |
|

$27,922,000
Callable Zero Coupon Notes, due November 29, 2039
| ● | The notes are senior unsecured debt securities issued by Bank of America
Corporation (“BAC”). All payments and the return of the principal amount on the notes are subject to our credit risk. |
| ● | The notes priced on November 26 2024. Subject to our redemption right,
the notes will mature on November 29, 2039. |
| ● | The notes do not pay any interest. |
| ● | We have the right to redeem all, but not less than all, of the notes on
November 29, 2025, and on each subsequent Call Date (as defined on page PS-3). If redeemed, the amount that you receive upon redemption
will reflect an accretion on the principal amount at the accrual yield of 8.27% per annum (non-compounding) as of the applicable Call
Date, plus, a supplemental redemption amount that accrues on the principal amount at a rate of 1.00% per annum (non-compounding). You
will only receive the supplemental redemption amount if we choose to exercise our redemption right. |
| ● | If the notes are not redeemed, at maturity, you will receive $2,240.50 per note. This amount is less
than the amount that you would have received if we redeemed the notes on the final Call Date. |
| ● | The notes are issued in minimum denominations of $1,000 and whole multiples of $1,000 in excess of $1,000. |
| ● | The notes will not be listed on any securities exchange. |
| ● | The CUSIP number for the notes is 06055JHM4. |
Potential purchasers of the notes should consider the information
in “Risk Factors” beginning on page PS-6 of this pricing supplement, page S-6 of the attached prospectus supplement, and page
7 of the attached prospectus.
The notes:
Are Not FDIC Insured |
Are Not Bank Guaranteed |
May Lose Value |
|
Per Note |
|
Total |
|
Public Offering
Price (1) |
100.00% |
|
$27,922,000.00 |
|
Underwriting
Discount (1)(2) |
1.50% |
|
$418,830.00 |
|
Proceeds (before
expenses) to BAC |
98.50% |
|
$27,503,170.00 |
|
(1) Certain
dealers who purchase the notes for sale to certain fee-based advisory accounts may forgo some or all of their selling concessions,
fees or commissions. The price to public for investors purchasing the notes in these accounts may be as low as $985.00 (98.50%) per
$1,000 in principal amount of the notes. See “Supplemental Plan of Distribution—Conflicts of Interest” in this
pricing supplement.
(2)
We or one of our affiliates may pay varying selling concessions of up to 1.50% in connection with
the distribution of the notes to other registered broker-dealers.
The notes are unsecured and unsubordinated obligations and
are not savings accounts, deposits, or other obligations of a bank. The notes are not guaranteed by Bank of America, N.A. or any other
bank, and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, and involve investment risks.
None of the Securities and Exchange Commission, nor any state securities commission, nor any
other regulatory body has approved or disapproved of these notes or passed upon the adequacy or accuracy of this pricing supplement,
the accompanying prospectus supplement, or the accompanying prospectus. Any representation to the contrary is a criminal offense.
We will deliver the notes in book-entry form only through The
Depository Trust Company on November 29, 2024 against payment in immediately available funds.
Series
P MTN prospectus supplement dated December 30, 2022 and prospectus dated December 30, 2022
BofA Securities |
UBS Financial Services Inc. |
SUMMARY OF TERMS
This pricing supplement supplements
the terms and conditions in the prospectus, dated December 30, 2022, as supplemented by the Series P MTN prospectus supplement, dated
December 30, 2022 (as so supplemented, together with all documents incorporated by reference, the “prospectus”), and should
be read with the prospectus.
|
• |
Title of the Series: |
Callable Zero Coupon Notes,
due November 29, 2039 |
|
|
|
|
• |
Aggregate Principal Amount Initially Being Issued: |
$27,922,000 |
|
|
|
|
• |
Issue Date: |
November 29, 2024 |
|
|
|
|
• |
CUSIP No.: |
06055JHM4 |
|
|
|
|
• |
Maturity Date: |
November 29, 2039 |
|
|
|
|
• |
Minimum Denominations: |
$1,000 and multiples of $1,000 in
excess of $1,000 |
|
|
|
|
• |
Ranking: |
Senior, unsecured |
|
|
|
|
• |
Accrual Yield: |
8.27% per annum (non-compounding). |
|
|
|
|
• |
Day Count Fraction: |
30/360 |
|
|
|
|
• |
Payment at Maturity: |
Unless earlier redeemed, on the maturity
date, you will receive $2,240.50 per note. This amount is less than the amount that you would have received if we redeemed the notes
on the final Call Date. |
|
|
|
|
• |
Optional Early Redemption: |
We have the right to redeem all, but
not less than all, of the notes on November 29, 2025 and on each subsequent Call Date. The redemption price with respect to each Call
Date is specified under “Call Dates and Redemption Price” below and reflects the accreted value as of the applicable Call
Date plus a supplemental redemption amount that accrues on the principal amount at a rate of 1.00% per annum (non-compounding) from and
including the issue date to but excluding the applicable Call Date. In order to call the notes, we will give notice at least five business
days but not more than 60 calendar days before the specified Call Date. |
|
• |
Call
Dates and Redemption Price: |
|
Call Date |
Accreted Value per Note on
Call Date |
Supplemental Redemption
Amount per Note |
Redemption Price Per Note |
November 29, 2025 |
$1,082.70
|
$10.00 |
$1,092.70
|
November
29, 2026 |
$1,165.40 |
$20.00 |
$1,185.40 |
November 29, 2027 |
$1,248.10 |
$30.00 |
$1,278.10 |
November
29, 2028 |
$1,330.80 |
$40.00 |
$1,370.80 |
November 29, 2029 |
$1,413.50 |
$50.00 |
$1,463.50 |
November 29, 2030 |
$1,496.20 |
$60.00 |
$1,556.20 |
November 29, 2031 |
$1,578.90 |
$70.00 |
$1,648.90 |
November 29, 2032 |
$1,661.60 |
$80.00 |
$1,741.60 |
November 29, 2033 |
$1,744.30 |
$90.00 |
$1,834.30 |
November 29, 2034 |
$1,827.00 |
$100.00 |
$1,927.00 |
November 29, 2035 |
$1,909.70 |
$110.00 |
$2,019.70 |
November 29, 2036 |
$1,992.40 |
$120.00 |
$2,112.40 |
November 29, 2037 |
$2,075.10 |
$130.00 |
$2,205.10 |
November 29, 2038 |
$2,157.80 |
$140.00 |
$2,297.80 |
|
• |
Business Days: |
New York |
|
|
|
|
• |
Business Day Convention: |
Following, unadjusted |
|
|
|
|
• |
Repayment at Option of Holder: |
None |
|
|
|
|
• |
Record Dates: |
For book-entry only notes, one business
day in New York, New York prior to the Call Date. If notes are not held in book-entry only form, the record dates will be the fifteenth
calendar day preceding such Call Date, whether or not such record date is a business day. |
|
|
|
|
• |
Events of Default and
Rights of Acceleration: |
If an event of default (as defined in the indenture relating to the notes) occurs and is continuing, holders of the notes may accelerate the maturity of the notes, as described under “Description of Debt Securities of Bank of America Corporation—Events of Default and Rights of Acceleration; Covenant Breaches” in the prospectus. Upon an event of default, the amount due and payable per note will be calculated in accordance with the following formula: |
|
|
|
|
|
|
|
$1,000 x (1 + Accrual Yield x Y) |
|
|
|
|
|
For purposes of the above formula, “Y” will equal the quotient of (a) the number of days (calculated on the basis of a 360-day year consisting of 12 months of 30 days each) from (and including) the issue date to (but excluding) the date upon which the principal amount of the notes has been accelerated divided by (b) 360. |
|
|
For an avoidance of doubt, holders of the notes will not be entitled to receive any supplemental redemption amount upon an event of default. |
|
|
|
|
|
In case of an event of default, the notes will not bear a default interest rate. If a bankruptcy proceeding is commenced in respect of us, your claim may be limited, under the U.S. Bankruptcy Code, to the original public offering price of the notes. |
|
|
|
|
• |
Calculation Agent: |
Merrill Lynch Capital
Services, Inc. |
|
|
|
|
• |
Listing: |
None |
Certain terms used and not defined in this document have the meanings ascribed
to them in the prospectus supplement and prospectus. Unless otherwise indicated or unless the context requires otherwise, all references
in this pricing supplement to “we,” “us,” “our,” or similar references are to BAC.
RISK FACTORS
Your investment in the notes entails significant
risks, many of which differ from those of a conventional security. Your decision to purchase the notes should be made only after carefully
considering the risks of an investment in the notes, including those discussed below, with your advisors in light of your particular circumstances.
The notes are not an appropriate investment for you if you are not knowledgeable about significant elements of the notes or financial
matters in general.
Structure-related Risks
The notes do not pay interest. There
will be no periodic interest payments on the notes as there would be on a conventional fixed-rate or floating-rate debt security having
the same maturity. Any return that you receive on the notes may be less than the return you would earn if you purchased a conventional
debt security with the same maturity date. As a result, your investment in the notes may not reflect the full opportunity cost to you
when you consider factors, such as inflation, that affect the time value of money.
The notes are subject to our early redemption.
We may redeem all, but not less than all, of the notes on any Call Date on or after November 29, 2025. If we elect to redeem the notes
prior to maturity, we will do so at a time that is advantageous for us but when it may not be in your interest for us to do so, such as
when prevailing interest rates are lower than the return represented by the applicable redemption price payable on a Call Date. The notes
are less likely to be redeemed if the return represented by the applicable redemption price with respect to a Call Date is higher than
the return represented by the payment at maturity. As a result, we may not exercise our option to redeem the notes prior to maturity and
you may not be able to receive an amount in cash that is greater than the payment at maturity even though the return represented by the
applicable redemption price for one or more Call Dates may be higher than the return represented by the payment at maturity.
In the event that we redeem the notes, you
will receive the redemption price applicable to that Call Date, which is equal to the accreted value (non-compounding) as of the relevant
Call Date plus a supplemental redemption amount that accrues on the principal amount at a rate of 1.00% per annum (non-compounding). If
you intend to purchase the notes, you must be willing to have the notes redeemed as early as the first Call Date. No further payments
will be made on the notes after they have been redeemed and you will lose the opportunity to receive any higher redemption price that
otherwise might have been payable on a later date. If we redeem the notes prior to the maturity date, you may not be able to reinvest
your proceeds from the redemption in an investment with a return that is as high as the return on the notes would have been if they had
not been redeemed, or that has a similar level of risk.
You will not receive the supplemental redemption
amount unless we redeem the notes prior to maturity. If we do not redeem the notes prior to maturity, the payment at maturity will
be $2,240.50 per note, and the per annum yield on the notes will be less than the per annum yield you would have received if we had redeemed
the notes.
Payments on the notes are subject to
our credit risk, and actual or perceived changes in our creditworthiness are expected to affect the value of the notes. The notes
are our senior unsecured debt securities. As a result, your receipt of all payments on the notes is dependent upon our ability to repay
our obligations on the applicable payment date. No assurance can be given as to what our financial condition will be at any time during
the term of the notes or on the maturity date. If we become unable to meet our financial obligations as they become due, you may not receive
the amounts payable under the terms of the notes.
Our credit ratings are an assessment by
ratings agencies of our ability to pay our obligations, including our obligations under the notes. Consequently, our perceived creditworthiness
and actual or anticipated decreases in our credit ratings or increases in our credit spreads prior to the maturity date of the notes may
adversely affect the market value of the notes. However, because your return on the notes generally depends upon factors in addition to
our ability to pay our obligations, such as the difference between the accrual yield on the notes and current market interest rates, an
improvement in our credit ratings will not reduce the other investment risks related to the notes.
We are subject to the Federal Reserve’s
final rules requiring U.S. G-SIBs to maintain minimum amounts of long-term debt meeting specified eligibility requirements. Under
the rules of the Federal Reserve relating to total loss-absorbing capacity (the “TLAC Rules”), Bank of America Corporation,
as a U.S. G-SIB, is required to, among other things, maintain minimum amounts of unsecured external long-term debt satisfying
certain eligibility criteria (“eligible LTD”) and other loss-absorbing capacity for the purpose of absorbing its losses in
a resolution proceeding under either the U.S. Bankruptcy Code or Title II of the Financial Reform Act. The notes include terms required
by the TLAC Rules in order to qualify as eligible LTD. Actions required to comply with the TLAC Rules could impact our funding and liquidity
risk management plans.
Please see the discussions under “Risk
Factors — Risks Relating to Debt Securities Generally — Events for which acceleration rights under Bank of America’s
senior debt securities may be exercised are more limited than those available pursuant to the terms of its outstanding senior debt securities
issued prior to January 13, 2017” in the accompanying prospectus and “Description of Debt Securities of Bank of America
Corporation— Financial Consequences to Unsecured Debtholders of Single Point of Entry Resolution Strategy” in the accompanying
prospectus for more information regarding the impact of the TLAC Rules on the notes.
Valuation- and Market-related Risks
We have included in the terms of the
notes the costs of developing, hedging, and distributing them, and the price, if any, at which you may sell the notes in any secondary
market transaction will likely be lower than the public offering price due to, among other things, the inclusion of these costs. In
determining the economic terms of the notes, and consequently the potential return on the notes to you, a number of factors are taken
into account. Among these factors are certain costs associated with developing, hedging, and offering the notes.
Assuming there is no change in market conditions
or any other relevant factors, the price, if any, at which the selling agent or another purchaser might be willing to purchase the notes
in a secondary market transaction is expected to be lower than the price that you paid for them. This is due to, among other things, the
inclusion of these costs, and the costs of unwinding any related hedging.
The quoted price of any of our affiliates for the notes could be
higher or lower than the price that you paid for them.
We cannot assure
you that a trading market for the notes will ever develop or be maintained. We will not list the notes on any securities exchange.
We cannot predict how the notes will trade in any secondary market, or whether that market will be liquid or illiquid.
The development of a trading market for
the notes will depend on our financial performance and other factors. The number of potential buyers of the notes in any secondary market
may be limited. We anticipate that our affiliate, BofA Securities, Inc. ("BofAS"), will act as a market-maker for the notes,
but neither BofAS nor any of our other affiliates is required to do so. BofAS may discontinue its market-making activities as to the notes
at any time. To the extent that BofAS engages in any market-making activities, it may bid for or offer the notes. Any price at which BofAS
may bid for, offer, purchase, or sell any notes may differ from the values determined by pricing models that it may use, whether as a
result of dealer discounts, mark-ups, or other transaction costs. These bids, offers, or completed transactions may affect the prices,
if any, at which the notes might otherwise trade in the market.
In addition, if at any time BofAS were
to cease acting as a market-maker for the notes, it is likely that there would be significantly less liquidity in the secondary market
and there may be no secondary market at all for the notes. In such a case, the price at which the notes could be sold likely would be
lower than if an active market existed and you should be prepared to hold the notes until maturity.
Many economic and
other factors will impact the market value of the notes. The market for, and the market value of, the notes may be affected by a number
of factors that may either offset or magnify each other, including:
| • | the time remaining to maturity of the notes; |
| • | the aggregate amount outstanding of the notes; |
| • | our right to redeem the notes on the dates set forth above; |
| • | the level, direction, and volatility of market interest rates generally
(in particular, increases in U.S. interest rates, which may cause the market value of the notes to decrease); |
| • | general economic conditions of the capital markets in the United States; |
| • | geopolitical conditions and other financial, political, regulatory, and
judicial events that affect the capital markets generally; |
| • | our financial condition and creditworthiness; and |
| • | any market-making activities with respect to the notes. |
Conflict-related Risks
Our trading and hedging activities may
create conflicts of interest with you. We or one or more of our broker-dealer affiliates, including BofAS, may engage in trading activities
related to the notes that are not for your account or on your behalf. We also expect to enter into arrangements to hedge the market risks
associated with our obligation to pay the amounts due under the notes. We may seek competitive terms in entering into the hedging arrangements
for the notes, but are not required to do so, and we may enter into such hedging arrangements with one of our subsidiaries or affiliates.
This hedging activity is expected to result in a profit to those engaging in the hedging activity, which could be more or less than initially
expected, but which could also result in a loss for the hedging counterparty. These trading and hedging activities may present a conflict
of interest between your interest in the notes and the interests we and our affiliates may have in our proprietary accounts, in facilitating
transactions, including block trades, for our other customers, and in accounts under our management. These trading and hedging activities
could influence secondary trading in the notes or otherwise could be adverse to your interests as a holder of the notes.
U.S. FEDERAL INCOME TAX SUMMARY
The following summary of the material U.S.
federal income tax considerations of the acquisition, ownership, and disposition of the notes supplements, and to the extent inconsistent
supersedes, the discussion under “U.S. Federal Income Tax Considerations” in the accompanying prospectus and is not exhaustive
of all possible tax considerations. This summary is based upon the Internal Revenue Code of 1986, as amended (the “Code”),
regulations promulgated under the Code by the U.S. Treasury Department (“Treasury”) (including proposed and temporary regulations),
rulings, current administrative interpretations and official pronouncements of the Internal Revenue Service (the “IRS”), and
judicial decisions, all as currently in effect and all of which are subject to differing interpretations or to change, possibly with retroactive
effect. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the
tax consequences described below. This summary does not include any description of the tax laws of any state or local governments, or
of any foreign government, that may be applicable to a particular holder.
This summary is directed solely to U.S.
Holders and Non-U.S. Holders (each as defined in the accompanying prospectus) that, except as otherwise specifically noted, will purchase
the notes upon original issuance and will hold the notes as capital assets within the meaning of Section 1221 of the Code, which generally
means property held for investment, and that are not excluded from the discussion under “U.S. Federal Income Tax Considerations”
in the accompanying prospectus. This discussion does not address the tax consequences applicable to holders subject to Section 451(b)
of the Code. This summary assumes the issue price of the notes, as determined for U.S. federal income tax purposes, equals the principal
amount thereof.
You should consult your own tax advisor
concerning the U.S. federal income tax consequences to you of acquiring, owning, and disposing of the notes, as well as any tax consequences
arising under the laws of any state, local, foreign, or other tax jurisdiction and the possible effects of changes in U.S. federal or
other tax laws.
U.S. Holders
Our tax counsel, Sidley Austin LLP, is of the opinion that
the notes will be issued with original issue discount (“OID”) (and without any “qualified stated interest”) each
as defined and described under “U.S. Federal Income Tax Considerations—General— Consequences to U.S. Holders”
in the accompanying prospectus). Accordingly, a U.S. Holder of a note will generally be required to accrue OID into income under the constant
yield method, regardless of the U.S. Holder’s regular method of accounting. Thus, a U.S. Holder will be required to include OID
in income in advance of the receipt of the related cash payments. Under these rules, a U.S. Holder generally will have to include in income
increasingly greater amounts of OID in successive accrual periods. The amount of OID included in each year on a constant yield basis will
be lower than the amount determined by reference to the yield implied by the redemption schedule described above in “Summary of
Terms—Call Dates and Redemption Price” unless the notes remain outstanding to maturity.
You should consult the discussion under “U.S. Federal
Income Tax Considerations—General—Consequences to U.S. Holders” in the accompanying prospectus as it relates to debt
instruments bearing OID for a description of the consequences to you of the ownership and disposition of the notes.
The following table states the amount of OID expected to accrue
with respect to a note for each accrual period based on the current terms of the notes and assuming the notes will remain outstanding
to the stated maturity date.
Accrual Period |
OID Deemed to Accrue During
Accrual Period (per $1,000.00
principal amount of the Notes) |
Total OID Deemed to Have
Accrued from Original Issue
Date (per $1,000.00 principal
amount of the Notes) as of End
of Accrual Period |
November 29, 2024 through December 31, 2024 |
$4.9148 |
$4.9148 |
January 1, 2025 through December 31, 2025 |
$55.5239 |
$60.4387 |
January 1, 2026 through December 31, 2026 |
$58.5917 |
$119.0304 |
January 1, 2027 through December 31, 2027 |
$61.7977 |
$180.8281 |
January 1, 2028 through December 31, 2028 |
$65.2767 |
$246.1048 |
January 1, 2029 through December 31, 2029 |
$68.8502 |
$314.9550 |
January 1, 2030 through December 31, 2030 |
$72.6544 |
$387.6094 |
January 1, 2031 through December 31, 2031 |
$76.6298 |
$464.2391 |
January 1, 2032 through December 31, 2032 |
$80.9437 |
$545.1828 |
January 1, 2033 through December 31, 2033 |
$85.3750 |
$630.5578 |
January 1, 2034 through December 31, 2034 |
$90.0922 |
$720.6500 |
January 1, 2035 through December 31, 2035 |
$95.0217 |
$815.6717 |
January 1, 2036 through December 31, 2036 |
$100.3711 |
$916.0428 |
January 1, 2037 through December 31, 2037 |
$105.8659 |
$1,021.9086 |
January 1, 2038 through December 31, 2038 |
$111.7152 |
$1,133.6239 |
January 1, 2039 through November 29, 2039 |
$106.8761 |
$1,240.5000 |
Upon the sale, exchange, redemption, retirement, or other disposition
of a note, a U.S. Holder will recognize gain or loss equal to
the difference between the amount realized upon the sale, exchange, redemption,
retirement, or other disposition and the U.S. Holder’s adjusted tax basis in the note. A U.S. Holder’s adjusted tax basis
in a note generally will be the cost of the note to such U.S. Holder, increased by any OID previously included in income with respect
to the note. Any gain or loss realized on the sale, exchange, redemption, retirement, or other disposition of a note generally will be
capital gain or loss and will be long-term capital gain or loss if the note has been held for more than one year. The ability of U.S.
Holders to deduct capital losses is subject to limitations under the Code.
Non-U.S. Holders
Please see the discussion under “U.S. Federal Income
Tax Considerations—General—Consequences to Non-U.S. Holders” in the accompanying prospectus for the material U.S. federal
income tax consequences that will apply to Non-U.S. Holders of the notes.
Backup Withholding and Information Reporting
Please see the discussion under “U.S. Federal Income
Tax Considerations—General—Backup Withholding and Information Reporting” in the accompanying prospectus for a description
of the applicability of the backup withholding and information reporting rules to payments made on the notes.
SUPPLEMENTAL PLAN OF DISTRIBUTION—CONFLICTS
OF INTEREST
Our broker-dealer subsidiary, BofAS, will act
as our selling agent in connection with the offering of the notes. The selling agent is a party to the distribution agreement described
in “Supplemental Plan of Distribution (Conflicts of Interest)” beginning on page S-51 of the accompanying prospectus supplement.
The selling agent will receive the compensation
set forth on the cover page of this pricing supplement as to the notes sold through its efforts. The selling agent is a member of the
Financial Industry Regulatory Authority, Inc. (“FINRA”). Accordingly, the offering of the notes will conform to the requirements
of FINRA Rule 5121. We or one of our affiliates may pay varying selling concessions of up to 1.50% in connection with the distribution
of the notes to other registered broker-dealers. Certain dealers who purchase the notes for sale to certain fee-based advisory accounts
may forgo some or all of their selling concessions, fees, or commissions. The price to public for investors purchasing the notes in these
accounts may be as low as $985.00 per $1,000 in principal amount of the notes.
If all of the offered notes are not sold
on the pricing date at the public offering price, then the selling agent and/or dealers may offer the notes for sale in one or more transactions
at an offering price that may be at a premium to the public offering price. These sales may occur at market prices prevailing at the time
of sale, at prices related to market prices or at negotiated prices.
The selling agent is not acting as your
fiduciary or advisor solely as a result of the offering of the notes, and you should not rely upon any communication from the selling
agent in connection with the notes as investment advice or a recommendation to purchase the notes. You should make your own investment
decision regarding the notes after consulting with your legal, tax, and other advisors.
We will deliver the Notes against payment therefor
in New York, New York on a date that is greater than one business day following the pricing date. Under Rule 15c6-1 of the Securities
Exchange Act of 1934, trades in the secondary market generally are required to settle in one business day, unless the parties to any such
trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes more than one business day prior to the original
issue date will be required to specify alternative settlement arrangements to prevent a failed settlement.
Under the terms of our distribution agreement
with BofAS, BofAS will purchase the notes from us on the issue date as principal at the purchase price indicated on the cover of this
pricing supplement, less the indicated underwriting discount.
BofAS may sell the
notes to other broker-dealers that will participate in the offering, at an agreed discount to the principal amount. Each of those broker-dealers
may sell the notes to one or more additional broker-dealers. BofAS has informed us that these discounts may vary from dealer to dealer
and that not all dealers will purchase or repurchase the notes at the same discount.
BofAS and any of our other broker-dealer affiliates
may use this pricing supplement, and the accompanying prospectus supplement and prospectus for offers and sales in secondary market transactions
and market-making transactions in the notes. Our affiliates may act as principal or agent in these transactions, and any such sales will
be made at prices related to prevailing market prices at the time of the sale. However, none of BAC, BofAS or any of our broker-dealer
affiliates are obligated to engage in any secondary market transactions and/or market-making transactions or otherwise purchase the notes
from the holders in such transactions.
European Economic Area and United Kingdom
None of this pricing supplement, the accompanying
prospectus or the accompanying prospectus supplement is a prospectus for the purposes of the Prospectus Regulation (as defined below).
This pricing supplement, the accompanying prospectus and the accompanying prospectus supplement have been prepared on the basis that any
offer of notes in any Member State of the European Economic Area (the “EEA”) or in the United Kingdom (each, a “Relevant
State”) will only be made to a legal entity which is a qualified investor under the Prospectus Regulation (“Qualified Investors”).
Accordingly any person making or intending to make an offer in that Relevant State of notes which are the subject of the offering contemplated
in this pricing supplement, the accompanying prospectus and the accompanying prospectus supplement may only do so with respect to Qualified
Investors. BAC has not authorized, nor does it authorize, the making of any offer of notes other than to Qualified Investors. The expression
“Prospectus Regulation” means Regulation (EU) 2017/1129.
Prohibition Of Sales To EEA And United
Kingdom Retail Investors – The notes are not intended to be offered, sold or otherwise made available to and should not be offered,
sold or otherwise made available to any retail investor in the EEA or in the United Kingdom. For these purposes: (a) a retail investor
means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU, as amended
(“MiFID II”); or (ii) a customer within the meaning of Directive (EU) 2016/97 (the Insurance Distribution Directive), where
that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified
investor as defined in the Prospectus Regulation; and (b) the expression “offer” includes the communication in any form and
by any means of sufficient information on the terms of the offer and the notes to be offered so as to enable an investor to decide to
purchase or subscribe for the notes. Consequently no key information document required by Regulation (EU) No 1286/2014, as amended (the
“PRIIPs Regulation”) for offering or selling the notes or otherwise making them available to retail investors in the EEA or
in the United Kingdom has been prepared and therefore offering or selling the notes or otherwise making them available to any retail investor
in the EEA or in the United Kingdom may be unlawful under the PRIIPs Regulation.
United Kingdom
The communication of this pricing supplement,
the accompanying prospectus supplement, the accompanying prospectus and any other document or materials relating to the issue of the notes
offered hereby is not being made, and such documents and/or materials have not been approved, by an authorized person for the purposes
of section 21 of the United Kingdom’s Financial Services and Markets Act 2000, as amended (the “FSMA”). Accordingly,
such documents and/or materials are not being distributed to, and must not be passed on to, the general public in the United Kingdom.
The communication of such documents and/or materials as a financial promotion is only being made to those persons in the United Kingdom
who have professional experience in matters relating to investments and who fall within the definition of investment professionals (as
defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Financial
Promotion Order”)), or who fall within Article 49(2)(a) to (d) of the Financial Promotion Order, or who are any other persons to
whom it may otherwise lawfully be made under the Financial Promotion Order (all such persons together being referred to as “relevant
persons”). In the United Kingdom, the notes offered hereby are only available to, and any investment or investment activity to which
this pricing supplement, the accompanying prospectus supplement and the accompanying prospectus relates will be engaged in only with,
relevant persons. Any person in the United Kingdom that is not a relevant person should not act or rely on this pricing supplement, the
accompanying prospectus supplement or the accompanying prospectus or any of their contents.
Any invitation or inducement to engage
in investment activity (within the meaning of Section 21 of the FSMA) in connection with the issue or sale of the notes may only be communicated
or caused to be communicated in circumstances in which Section 21(1) of the FSMA does not apply to BAC.
All applicable provisions of the FSMA must
be complied with in respect to anything done by any person in relation to the notes in, from or otherwise involving the United Kingdom.
VALIDITY OF
THE NOTES
In the opinion of McGuireWoods LLP, as
counsel to BAC, when the trustee has made the appropriate entries or notations on Schedule 1 to the master global note that represents
the notes (the “Master Note”) identifying the notes offered hereby as supplemental obligations thereunder in accordance with
the instructions of BAC, and the notes have been delivered against payment therefor as contemplated in this pricing supplement and the
related prospectus and prospectus supplement, all in accordance with the provisions of the indenture governing the notes, such notes
will be the legal, valid and binding obligations of BAC, subject to the effects of applicable bankruptcy, insolvency (including laws
relating to preferences, fraudulent transfers and equitable subordination), reorganization, moratorium and other similar laws affecting
creditors’ rights generally, and to general principles of equity. This opinion is given as of the date of this pricing supplement
and is limited to the Delaware General Corporation Law (including the statutory provisions, all applicable provisions of the Delaware
Constitution and reported judicial decisions interpreting the foregoing) and the laws of the State of New York as in effect on the date
hereof. In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery
of the indenture governing the notes and due authentication of the Master Note, the validity, binding nature and enforceability of the
indenture governing the notes with respect to the trustee, the legal capacity of individuals, the genuineness of signatures, the authenticity
of all documents submitted to McGuireWoods LLP as originals, the conformity to original documents of all documents submitted to McGuireWoods
LLP as copies thereof, the authenticity of the originals of such copies and certain factual matters, all as stated in the opinion letter
of McGuireWoods LLP dated December 8, 2022, which has been filed as an exhibit to the Registration Statement (File No. 333-268718) of
BAC, filed with the SEC on December 8, 2022.
S-3
424B2
EX-FILING FEES
333-268718
0000070858
BANK OF AMERICA CORP /DE/
0000070858
2024-11-27
2024-11-27
iso4217:USD
xbrli:pure
xbrli:shares
Calculation of Filing Fee Tables
|
S-3
|
BANK OF AMERICA CORP /DE/
|
The maximum aggregate offering price of the securities to which the prospectus relates is $27,922,000.00. The prospectus is a final prospectus for the related offering.
|
|
v3.24.3
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_FeeExhibitTp |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:feeExhibitTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_RegnFileNb |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_SubmissionLineItems |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
ffd_SubmissnTp |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.24.3
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_FeesSummaryLineItems |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_FnlPrspctsFlg |
Namespace Prefix: |
ffd_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_NrrtvDsclsr |
Namespace Prefix: |
ffd_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230
+ Details
Name: |
ffd_NrrtvMaxAggtOfferingPric |
Namespace Prefix: |
ffd_ |
Data Type: |
ffd:nonNegative100TMonetary2ItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Bank of America (NYSE:BML-L)
Historical Stock Chart
From Jan 2025 to Feb 2025
Bank of America (NYSE:BML-L)
Historical Stock Chart
From Feb 2024 to Feb 2025